N
NeXeption
NeXeption - Building Innovative Pharmaceutical Companies
About NeXeption
NeXeption is a company that specializes in building innovative pharmaceutical companies by bringing together pharmaceutical product opportunities, management expertise, and the necessary funding. The company focuses on rapidly advancing therapies through clinical and regulatory milestones. NeXeption actively seeks development-ready assets across a broad range of therapeutic areas, making it a partner of choice for accelerating therapies. The company serves pharmaceutical companies looking for alternative pipeline development paths for non-progressing assets or science, as well as investors seeking high returns. NeXeption's business model involves identifying promising pharmaceutical products, assembling a team of experts, securing funding, and advancing these products through the necessary clinical and regulatory stages. The company makes money through successful development and commercialization of these pharmaceutical products, often resulting in high returns for investors.
Source: Dealroom company dataAt a glance
- Founded
- 2011
- Headquarters
- Malvern, United States
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
New Science Ventures
Third Point Ventures- PIPalo Alto Investors
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about NeXeption on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See NeXeption on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.